Merck Research Program To Focus On Nine Priority Diseases
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck will prioritize its research efforts on nine disease areas as part of a five-pronged strategy to jumpstart growth
You may also be interested in...
Merck Research Appointment Reflects Firm's Emphasis On Diabetes, Obesity
Academic Rossetti will have responsibility over scientific direction of Merck's pipeline in the therapeutic areas as VP and franchise head.
Merck Research Appointment Reflects Firm's Emphasis On Diabetes, Obesity
Academic Rossetti will have responsibility over scientific direction of Merck's pipeline in the therapeutic areas as VP and franchise head.
Merck’s Biotech Pipeline Gets A Boost From Two Acquisitions
Merck will buy the monoclonal antibody developer Abmaxis and yeast glycoengineering specialist GlycoFi.